Co-Authors
This is a "connection" page, showing publications co-authored by Srinivas Murthy and Francois Lamontagne.
Connection Strength
1.947
-
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study. CMAJ Open. 2021 Jan-Mar; 9(1):E181-E188.
Score: 0.233
-
Barriers to supportive care during the Ebola virus disease outbreak in West Africa: Results of a qualitative study. PLoS One. 2018; 13(9):e0201091.
Score: 0.196
-
Early vasopressor use following traumatic injury: a systematic review. BMJ Open. 2017 Nov 17; 7(11):e017559.
Score: 0.186
-
Evidence-based guidelines for supportive care of patients with Ebola virus disease. Lancet. 2018 02 17; 391(10121):700-708.
Score: 0.184
-
Vasopressor use following traumatic injury: protocol for a systematic review. BMJ Open. 2017 02 28; 7(2):e014166.
Score: 0.177
-
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26; 385(9):790-802.
Score: 0.060
-
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26; 385(9):777-789.
Score: 0.060
-
Clinical trials in COVID-19 management & prevention: A meta-epidemiological study examining methodological quality. J Clin Epidemiol. 2021 11; 139:68-79.
Score: 0.060
-
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Med. 2021 Aug; 47(8):867-886.
Score: 0.060
-
Prophylaxis against covid-19: living systematic review and network meta-analysis. BMJ. 2021 04 26; 373:n949.
Score: 0.059
-
Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors. CJC Open. 2021 Jul; 3(7):965-975.
Score: 0.059
-
Risk of dispersion or aerosol generation and infection transmission with nasopharyngeal and oropharyngeal swabs for detection of COVID-19: a systematic review. BMJ Open. 2021 03 17; 11(3):e040616.
Score: 0.058
-
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. N Engl J Med. 2021 04 22; 384(16):1491-1502.
Score: 0.058
-
CMAJ. 2020 10 26; 192(43):E1323-E1333.
Score: 0.057
-
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020 10 06; 324(13):1317-1329.
Score: 0.057
-
Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020 07 30; 370:m2980.
Score: 0.056
-
Remdesivir for severe covid-19: a clinical practice guideline. BMJ. 2020 07 30; 370:m2924.
Score: 0.056
-
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design. Ann Am Thorac Soc. 2020 07; 17(7):879-891.
Score: 0.056
-
High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Can J Anaesth. 2020 09; 67(9):1217-1248.
Score: 0.055
-
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. CMAJ. 2020 05 19; 192(20):E536-E545.
Score: 0.055
-
Misinformation During the Coronavirus Disease 2019 Outbreak: How Knowledge Emerges From Noise. Crit Care Explor. 2020 Apr; 2(4):e0098.
Score: 0.055
-
Anti-Ebola therapy for patients with Ebola virus disease: a systematic review. BMC Infect Dis. 2019 May 02; 19(1):376.
Score: 0.051